GH Research GHRS
NASDAQ GHRS
$28.23 +0.31 (+1.11%)
As of: Sep 4, 2026 · 3:59 PM EDT

GH Research (GHRS) Free Cash Flow (2020 - 2026)

GH Research (GHRS) posted quarterly Free Cash Flow of -$12.3 million for Q4 2025, down 18.14% year-over-year from -$15.0 million in Q4 2024, and up 9.76% quarter-over-quarter from -$13.6 million in Q3 2025.

Analysis

GH Research (GHRS) Free Cash Flow (2020 - 2026) Analysis & Trends

GH Research's Free Cash Flow history runs 6 years deep, the most recent figure standing at -$12.3 million for Q4 2025.

  • In Q4 2025, Free Cash Flow fell 18.14% year-over-year to -$12.3 million; the TTM figure through Dec 2025 stood at -$43.4 million (down 2.83% YoY), while the FY2025 annual figure was -$43.4 million, down 2.83% from the prior year.
  • Free Cash Flow for Q4 2025 stood at -$12.3 million, up from -$13.6 million in the prior quarter.
  • The five-year high for Free Cash Flow was -$1.1 million in Q1 2021, with the low at -$13.6 million in Q3 2025.
  • The 5-year median for Free Cash Flow is -$8.7 million (2025), against an average of -$8.2 million.
  • The sharpest annual moves came in 2021 and 2024: Free Cash Flow slumped 11800.0% in 2021, then increased 12.4% in 2024.
  • GH Research's Free Cash Flow stood at -$3.9 million in 2021, then sank by 89.03% to -$7.5 million in 2022, then tumbled by 59.44% to -$11.9 million in 2023, then grew by 12.4% to -$10.4 million in 2024, then declined by 18.14% to -$12.3 million in 2025.
  • Business Quant data shows GHRS's Free Cash Flow at -$12.3 million in Q4 2025, -$13.6 million in Q3 2025, and -$8.9 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -563.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -389.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 437.80 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 292.04 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 477.44 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -95.09 Mn
10 GH Research 1.72 Bn 1.36 Bn - -15.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.01 Mn
Mar 31, 2026 -10.61 Mn
Dec 31, 2025 -12.31 Mn
Sep 30, 2025 -13.64 Mn
Jun 30, 2025 -8.91 Mn
Mar 31, 2025 -8.57 Mn
Dec 31, 2024 -10.42 Mn
Sep 30, 2024 -12.30 Mn
Jun 30, 2024 -9.93 Mn
Mar 31, 2024 -9.58 Mn
Dec 31, 2023 -8.06 Mn
Sep 30, 2023 -10.33 Mn
Jun 30, 2023 -7.98 Mn
Mar 31, 2023 -6.86 Mn
Dec 31, 2022 -6.98 Mn
Sep 30, 2022 -8.03 Mn
Jun 30, 2022 -5.26 Mn
Mar 31, 2022 -5.99 Mn
Dec 31, 2021 -3.74 Mn
Sep 30, 2021 -9.16 Mn